ClinicalTrials.Veeva

Menu

BioMonitor Master Study

B

Biotronik

Status

Completed

Conditions

ATRIAL FIBRILLATION, Syncope

Treatments

Device: BioMonitor

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The BioMonitor is an implantable cardiac monitor used to automatically detect and record episodes of arrhythmia in patients with bradycardia, tachycardia, asystole and atrial fibrillation. The study will be conducted to support regulatory approvals outside of Europe. This BioMonitor Master study is designed to investigate the clinical efficacy and safety of the BioMonitor.

Enrollment

152 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Suspected cardiac arrhythmia OR Previous AF diagnosis OR AF diagnosis before or after ablation procedure OR Stroke of unknown origin.

Exclusion criteria

  • Implanted ICD or cardiac pacemaker
  • Allergy to patch electrodes

Trial design

152 participants in 1 patient group

Implantable cardiac monitor diagnostics
Description:
Patients has standard indication for implantable cardiac monitor diagnostic.
Treatment:
Device: BioMonitor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems